Epistaxis may present early in HHT, but is typically mild in the pediatric period and is slightly worse in patients with HHT1.
Is Bevacizumab Effective for Reducing Epistaxis in Hereditary Hemorrhagic Telangiectasia?
Hereditary hemorrhagic telangiectasia (HHT), also known as Osler-Weber-Rendu syndrome, often manifests with epistaxis.
Bevacizumab Therapy Effective for Hereditary Hemorrhagic Telangiectasia
Does bevacizumab delivered as a submucosal and topical intranasal therapy effectively control hereditary hemorrhagic telangiectasia (HHT)-associated epistaxis?